Is there an optimal adjunct therapy to traditional cytotoxic induction?

The traditional cytotoxic induction regimen for acute myeloid leukemia (AML) is seven days of standard-dose cytarabine and three days of an anthracycline antibiotic (such as daunorubicin or idarubicin), commonly known as “7 + 3.” Many studies have been conducted to find an additional agent that migh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Best practice & research. Clinical haematology 2021-12, Vol.34 (4), p.101326-101326, Article 101326
1. Verfasser:	Michaelis, Laura C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia (AML) Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cladribine Clofarabine Cytarabine Cytarabine - therapeutic use Daunorubicin Daunorubicin - therapeutic use Gemtuzumab Humans Idarubicin Idarubicin - therapeutic use Induction Chemotherapy Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Lomustine Midostaurin Remission Induction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!